Nature Medicine, Published online: 14 April 2026; doi:10.1038/s41591-026-04317-6 A first-in-human phase 1 trial shows that intravitreal photoswitch therapy can be administered safely in advanced retinitis pigmentosa, with exploratory signals compatible with light responsiveness following treatment.
Nature Medicine published a clinical update in Research Highlights on 14 Apr 2026. The item focuses on Intravitreal photoswitch therapy in advanced retinitis pigmentosa: a phase 1 open-label trial. Open the detail page to review the full original feed content.